Astellas Reports the US FDA Listing of DIGITIVA to Manage Heart Failure
Shots:
- The US FDA has listed Astellas' non-invasive digital health solution, DIGITIVA, for heart failure management, enabling patients to monitor their health at home & promoting collaboration with HCPs
- The DIGITIVA solution comprises of Eko Health’s CORE 500 Digital Stethoscope, a heart failure-specific smartphone app built on Welldoc's platform & a clinical review team for patient data assessment. The app also offers educational materials from the American Heart Association for patients
- The clinical review team analyzes patient data such as heart failure-specific biomarkers, and alerts the patient's physician if intervention is needed, aiming to reduce acute decompensation events and re-hospitalizations
Ref: Astellas | Image: Astellas
Related News:- Astellas’ Padcev Plus Keytruda Receives the EC’s Approval to Treat Advanced Urothelial Cancer
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
